Telmisartan and Hydrochlorothiazide

Browse eMedTV's wide range of articles related to telmisartan and hydrochlorothiazide including topics such as generic telmisartan/hydrochlorothiazide, telmisartan/hydrochlorothiazide dosing, and what is telmisartan/hydrochlorothiazide used for?. Use the search box at the top-right corner of the page to find information about other health topics.

Description of Articles in Telmisartan and Hydrochlorothiazide

Telmisartan/hydrochlorothiazide is a combination medicine that is licensed to treat high blood pressure. This eMedTV article explains how the drug works and also discusses its effects, dosing information, and potential side effects.

What is telmisartan/hydrochlorothiazide used for? As this section of the eMedTV library explains, this prescription drug is commonly used for the treatment of high blood pressure in adults. An explanation of how the drug works is also included.

Common side effects of telmisartan/hydrochlorothiazide may include dizziness, diarrhea, or fatigue. This eMedTV segment lists other potential side effects, including serious problems to look out for, such as muscle pain or cramps.

Telmisartan/hydrochlorothiazide dosing guidelines generally start at 40 mg/12.5 mg a day. As this eMedTV Web page explains, however, your healthcare provider may choose to increase or decrease your dosage based on your response to the medication.

This eMedTV page contains a list of medicines that can cause drug interactions with telmisartan/hydrochlorothiazide, such as warfarin, diuretics, or narcotics. These interactions may cause effects from extreme low blood pressure to high blood sugar.

Those with severe kidney or liver disease shouldn't take telmisartan/hydrochlorothiazide. This eMedTV page lists more warnings and precautions with telmisartan/hydrochlorothiazide, including others who should avoid the drug and possible side effects.

A generic telmisartan/hydrochlorothiazide will not become available until 2020, at the earliest. As this eMedTV article explains, when the patent for the drug expires in 2020, other companies may begin manufacturing generic versions of it.